Innovation
Alsymo aims to treat patients with pulmonary hypertension
… suffering from pulmonary arterial hypertension, a rare and incurable disease, progress to treatment failure. To … founders of the start-up Alsymo, are focusing on a drug that acts on pulmonary vascular N-methyl-D-aspartate (NMDA) receptors. Approximately 50 out of …Published on: Wed 13/09/2023 - 15:48